Bassam Atallah, PharmD

An exciting new trial for #WNW - COBRRA compared apixaban vs rivaroxaban for VTE treatment and found a significantly decreased risk of bleeding associated with apixaban use (3.3% vs 7.1%); this RCT backs up the trend seen in retrospective data! nejm.org/doi/10.1056/NE…

Not noninferior = INFERIOR Take your blood thinners folks - still the gold standard for stroke prevention in patients with AF who don’t have clear contraindication to anticoagulation.

A messege from Dr Bassam Atallah: "On #WorldPharmacistsDay, we recognize the crucial role pharmacists play in advancing safe, effective, and evidence-based cardiac care. Thank you for your dedication to patients’ health." #EmiratesCardiacSociety #ECS @batallah08

ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools & techniques to recognize HoFH & HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ bit.ly/3vNLMqW #ACCEd #CholesterolEducationMonth

ICYMI: A new ACC/AHA Scientific Statement introduces the PREVENT risk calculator & details the supporting evidence & rationale behind its use. Learn more: bit.ly/41xhycz #hypertension @JACCJournals

eppro02.ativ.me/appinfo.php?pa… #AHA25

New in JACC HF: #Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in #HFpEF shorturl.at/pknri

🫀 In familial hypercholesterolemia (HeFH), artery changes start young—carotid plaque at 17♂ / 30♀, coronary plaque at 26♂ / 36♀. Triple checks 🩻 (carotid, coronary, CAC) improve risk stratification & prevention 💪 Full study 👉 jacc.org/doi/10.1016/j.… #JACCAsia #cvPrev

Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF. ja.ma/4meRfzV

AFIRE RCT: Rivaroxaban monotherapy yielded a consistent net clinical benefit across all age groups, especially in older patients with atrial fibrillation and stable coronary artery disease. ja.ma/3Jcoa9T

In frail, elderly #AFib patients previously on a vitamin K antagonist, switching to standard-dose direct-acting oral anticoagulant reduced stroke, fatal/intracranial bleeding, and death, despite more GI bleeding. jacc.org/doi/10.1016/j.… #JACC #DOAC

Kudos to @mfiuzat, @batallah08, Robert Page & Orly Vardeny for shedding light on the training, practice, & roles of HF pharmacists. jacc.org/doi/epdf/10.10…

🎤 Meet Dr. Bassam Atallah – Our Featured Speaker Join Dr. Atallah (UAE) on July 23 as he walks us through pharmacologic innovations in HCM care—from classic medications to emerging myosin inhibitors. With a decade of clinical and academic experience, Dr. Atallah brings a practical, evidence-based perspective. 📅 Don’t miss this live global session! 🔗 Free registration open now: us06web.zoom.us/webinar/regist… #ISCP2025 #CardioPharma #HeartHealth #MedicalWebinar @doreen_sy @ALorenzatti @PabloAvanzas @amartinezrubio @KojiHasegawa6 @jckaski @kjfilipiak @beaverspharmd @KarleziAlonso @VebionaBachtar @DanielPiskorz @DrPontecarlosi @santon74 @kit6750 @kfranco_c @JD_Bennetts @Risantilopezcar @jacktanwc

The Current Landscape of Training, Practice, and Roles of Pharmacists ... sciencedirect.com/science/articl…

Grateful for 10 years @CCAD !

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT) nej.md/41YkRZK Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA #Cardiology

Congratulations to ACCP member Bassam Atallah and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/1xGc50Vk7QC @JACCPJournal #OpenAccess #MakingAnImpact #ACCP

Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist‐led protocol - Alaryani - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library accpjournals.onlinelibrary.wiley.com/doi/full/10.10…

Bassam Atallah presented on “The Role of a Pharmacist in Outpatient Optimization of GDMT” @batallah08